Xilio Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Xilio Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2020 to Q3 2024.
  • Xilio Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.57M, a 15.4% decline year-over-year.
  • Xilio Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $6.85M, a 5.77% decline year-over-year.
  • Xilio Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $7.38M, a 12.4% decline from 2022.
  • Xilio Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $8.42M, a 69.9% increase from 2021.
  • Xilio Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $4.96M, a 283% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $6.85M $1.57M -$287K -15.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $7.14M $1.51M -$289K -16.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $7.42M $1.83M +$42K +2.35% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $7.38M $1.93M +$115K +6.34% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 $7.27M $1.86M -$10K -0.53% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $7.28M $1.8M -$909K -33.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $8.19M $1.79M -$238K -11.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $8.42M $1.82M -$256K -12.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 $8.68M $1.87M +$780K +71.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $7.9M $2.71M +$1.71M +170% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $6.19M $2.03M +$1.24M +156% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $4.96M $2.07M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-02
Q3 2021 $1.09M +$408K +59.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $1M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $794K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 $683K Jul 1, 2020 Sep 30, 2020 10-Q 2021-12-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.